-
LifeHealthcare shareholders to receive $3.75 per share in cash
-
Scheme Consideration represents a significant premium to pre-announcement share price
-
The Directors unanimously recommend that shareholders vote in favour of the Scheme, in the absence of a superior proposal and subject to the Independent Expert concluding that the Scheme is in the best interests of LifeHealthcare shareholders
For further information please download PDF attached:
Download this document
